HRTX FY 2013 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$152M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$31M

Operating Income

-$54M

Net Income

-$55M

EPS (Diluted)

$-3.42

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$42M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$76M

Total Liabilities

$7M

Stockholders' Equity

$69M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$646,000	-100.0%
Gross Profit	-$31M	-$14M	-119.7%
Operating Income	-$54M	-$24M	-128.5%
Net Income	-$55M	-$23M	-136.8%